Detalhe da pesquisa
1.
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.
Lancet Oncol;
24(9): 1018-1028, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37657461
2.
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gynecol Oncol;
179: 123-130, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37980767
3.
Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
Br J Cancer;
127(5): 844-854, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35618787
4.
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet;
397(10290): 2182-2193, 2021 06 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33991479
5.
Improved early detection of ovarian cancer using longitudinal multimarker models.
Br J Cancer;
122(6): 847-856, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31937926
6.
Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gynecol Oncol;
158(2): 316-322, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32561125
7.
Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel.
Br J Cancer;
121(6): 483-489, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31388184
8.
Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study.
J Med Genet;
55(8): 546-554, 2018 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29730597
9.
A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.
Br J Cancer;
117(5): 666-674, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28664912
10.
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Br J Cancer;
117(5): 619-627, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28742794
11.
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet;
387(10022): 945-956, 2016 Mar 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26707054
12.
Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study.
BMC Public Health;
17(1): 882, 2017 11 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29145813
13.
Protein Z: A putative novel biomarker for early detection of ovarian cancer.
Int J Cancer;
138(12): 2984-92, 2016 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26815306
14.
Socioeconomic indicators of health inequalities and female mortality: a nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
BMC Public Health;
15: 253, 2015 Mar 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25848938
15.
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Health Technol Assess;
: 1-81, 2023 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37183782
16.
Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials.
Health Technol Assess;
: 1-38, 2023 Aug 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37843101
17.
The UKCTOCS experience--reasons for hope?
Int J Gynecol Cancer;
22 Suppl 1: S18-20, 2012 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22543913
18.
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews.
Diagnostics (Basel);
12(5)2022 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35626184
19.
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data.
BMJ Open;
12(12): e059669, 2022 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36521881
20.
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar.
Trials;
22(1): 88, 2021 Jan 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33494753